Robert Rohling is a Professor at the University of British Columbia's Faculty of Applied Science, affiliated with the Department of Mechanical Engineering and holding a joint appointment with the Department of Electrical and Computer Engineering. As Director of the Institute of Computing, Information and Cognitive Systems (ICICS), his research focuses on biomedical engineering, medical imaging, robotics, and computational methods. B.A.Sc. (UBC) M.Eng. (McGill) Ph.D. (Cambridge) Rohling's work spans three primary research areas: medical imaging (3D ultrasound, spatial compounding, elasticity reconstruction), medical information systems (radiologist navigation tools for large image datasets), and robotic calibration for surgical applications. His multidisciplinary approach integrates mechanical and electrical engineering principles with clinical needs. Rohling's publications (2020-2022) reveal trends in advanced ultrasound techniques (e.g., shear wave vibro-elastography), AI-driven image processing (cycleGAN translation), and computational optimization for diagnostic accuracy. Keywords across his work include Medical Imaging, Biomedical Engineering, Robotics, and Computational Modeling. As director of the Robotics and Control Laboratory , Rohling leads interdisciplinary collaborations with industry and clinical partners to address practical challenges in medical diagnostics and surgical robotics. His research emphasizes translating engineering innovations into clinical practice.
Prof. Marcy Zenobi-Wong is a Full Professor at ETH Zurich's Department of Health Sciences and Technology, specializing in biofabrication and tissue engineering. Her research focuses on cartilage regeneration using advanced biomaterials, including nanofilm coatings and 3D printing techniques. She holds patents in tissue engineering and has pioneered methods like filamented light (FLight) biofabrication for creating anisotropic tissues. Her academic journey includes a B.Sc. from MIT (1985), M.Sc. and Ph.D. from Stanford (1987, 1990), followed by postdoctoral work at the University of Michigan. She leads the Biofabrication Group at ETH, developing therapies for joint repair and regenerative medicine. Courses taught include Biomedical Engineering and Materials and Mechanics in Medicine . Research highlights include engineered hydrogels for cartilage protection, CRISPR-driven gene editing in chondrocytes, and biohybrid neural interfaces. Her work bridges material science, cell biology, and clinical applications, with a focus on translational medicine. Collaborative projects involve creating elastic cartilage grafts for microtia reconstruction and volumetric printing of complex tissue constructs.
Brett Welch is an Assistant Professor and Biostatistician at the University of Houston with dual appointments in the Department of Communication Sciences and Disorders and the Department of Psychological, Health, and Learning Sciences within the College of Liberal Arts and Social Sciences. Dr. Welch's educational background includes: Ph.D. in Communication Science and Disorders from the University of Pittsburgh M.S. in Communication Sciences and Disorders from the University of Texas Rio Grande Valley B.S. in Linguistics from the University of Texas at Austin B.A. in Communication Sciences and Disorders – Speech-Language Pathology from the University of Texas at Austin Dr. Welch's research sits at the intersection of psychology and communication. He seeks to understand how psychological processes like personality and psychopathology influence communication behaviors, and conversely, how communication behaviors impact psycho-social well-being. His work leverages quantitative methods, cross-sectional studies, and intensive longitudinal designs to interrogate the dynamic interplay between psychological processes and voice and communication behaviors. This research aims to advance understanding of functional voice disorders, improve assessment of psychopathology, and promote well-being for people with and without communication disorders. Dr. Welch has received several notable awards: Honors Council of Academic Programs in Communication Sciences and Disorders PhD Scholarship (2024) New Century Scholars Doctoral Scholarship from the American Speech-Language-Hearing Foundation (2023) New Investigator Forum from The Voice Foundation (2021) As an academic, Dr. Welch serves as an ad hoc peer reviewer for various scientific journals in speech-language pathology and psychology. He is also a mentor in the Students to Empowered Professional Mentoring Program and a member of the American Speech-Language-Hearing Association. His teaching includes Special Problems: Introduction to Quantitative Modeling (COMD 8398). Dr. Welch maintains an active research program focused on the intersection of psychology and communication, with particular emphasis on voice disorders and their psychological correlates. His work combines biostatistical approaches with clinical insights to advance understanding in this specialized field.
David Erickson is the SC Thomas Sze Director and Sibley College Professor at Cornell University's Sibley School of Mechanical and Aerospace Engineering. He also holds a joint professorship in the Division of Nutritional Sciences. His research focuses on global health technologies, medical diagnostics, microfluidics, photonics, nanotechnology, and energy systems. He previously served as Associate Dean of Engineering for Research and Graduate Programs. Erickson leads the NIH-funded PORTENT Center for Point-of-Care Technologies in Global Health and has co-founded companies like Dimensional Energy and VitaScan to commercialize diagnostic and energy technologies. Education: B.Sc., Mechanical Engineering, University of Alberta (1999) M.A.Sc., Mechanical Engineering, University of Toronto (2001) Ph.D., Mechanical Engineering, University of Toronto (2004) Postdoctoral Scholar, Electrical Engineering, California Institute of Technology (2005) Research Interests: Erickson’s work spans global health diagnostics , nanobio applications , and clean energy innovation . He develops portable medical devices for low-resource settings, including smartphone-integrated diagnostic tools for malaria, iron deficiency, and cancer. His lab also pioneers photothermal reactors for CO2 conversion into sustainable fuels. Key areas include: Point-of-care testing for infectious diseases and nutritional deficiencies Nanofluidic and optofluidic technologies for biomolecular analysis Solar-driven energy systems for carbon-neutral fuels Awards: Presidential Early Career Award for Scientists and Engineers (2011) Fellowships from the Optical Society, ASME, and Canadian Academy of Engineering Carbon X-Prize Finalist (2019) for Dimensional Energy’s CO2-to-fuel technology Grants & Industry Collaboration: Erickson’s research is funded by NIH, NSF, ARPA-E, DOE, and USAID. His lab’s innovations have spun off start-ups addressing global health and energy challenges. Notable projects include: - Portable cancer diagnostics in sub-Saharan Africa using mobile phone-based systems - Solar-powered CO2 conversion reactors tested in Wyoming and Arizona Labs & Teams: The Erickson Lab collaborates with the Cornell Atkinson Center for Sustainability and the McGovern Center for Entrepreneurship. Key initiatives include the PORTENT Center and the Dimensional Energy CO2-to-fuel project.
Dr. Ahmet Acar is an Associate Professor at the Department of Biological Sciences, Middle East Technical University (METU), Ankara, Turkey. He leads the Cancer Precision Medicine and Drug Resistance Laboratory, focusing on understanding mechanisms of drug resistance in cancer. His research integrates experimental models, next-generation sequencing, and deep learning to address clinical challenges in cancer therapy. Dr. Acar holds a B.Sc. from METU's Biological Sciences department and a Ph.D. from the Cancer Research UK Manchester Institute. He completed postdoctoral training at the Institute of Cancer Research, London, and the University of Manchester. Research Interests: Drug resistance mechanisms, precision oncology, tumor microenvironment modeling, patient-derived organoids, computational pathology, and evolutionary cancer biology. His lab develops 2D/3D co-culture systems, PDO biobanks, and AI-driven histopathology tools to improve treatment strategies. Recent Work Trends: Recent publications emphasize tumor evolution modeling, matrix mechanics in drug resistance, and AI applications in histopathology. Collaborations with hospitals in Turkey and Europe support PDO biobank initiatives. His team explores evolutionary steering strategies to exploit collateral drug sensitivities. Labs/Teams: Precision Medicine and Drug Resistance Lab at METU focuses on interdisciplinary approaches combining wet-lab experiments with computational methods. Current projects include ex vivo tumor modeling and AI-driven diagnostic tools for oncology.
Changhuei Yang is the Thomas G. Myers Professor of Electrical Engineering, Bioengineering, and Medical Engineering at California Institute of Technology, serving as Executive Officer for Electrical Engineering and Investigator at Heritage Medical Research Institute. He holds a Ph.D. and three master's degrees from MIT, with appointments at Caltech since 2003. Research focuses on: Advanced microscopy techniques including Fourier Ptychography Wavefront shaping for biological tissue imaging Optical phase conjugation for deep-tissue applications Compact medical devices for cerebral monitoring Publications demonstrate leadership in computational imaging, with recent advances in stain-free embryo analysis, portable cerebral blood flow monitors, and high-resolution volumetric imaging techniques using neural representations. Honored as National Academy of Inventors member. Research applications span deep-tissue biochemical imaging, incisionless surgery, and optogenetic activation systems.
Professor Matthias Mann is a world-leading scientist serving as Director of the Proteomics and Signal Transduction department at the Max Planck Institute of Biochemistry in Martinsried, Germany, and Director of the Proteomics department at the Novo Nordisk Foundation Center for Protein Research, Faculty of Health Sciences, University of Copenhagen, Denmark. With an h-index exceeding 277 and over 350,000 citations, he is recognized as the highest cited German researcher and one of the most influential scientists globally in proteomics. His educational background includes: Ph.D. in Chemical Engineering from Yale University (1988) Master's Degree in Physics from Georg August University Göttingen (1984) Bachelor's of Arts in Mathematics from Georg August University Göttingen (1982) Professor Mann's research focuses on advancing mass spectrometry-based proteomics to understand biological systems at the protein level. His work spans technological developments in mass spectrometry, bioinformatics and computational analysis, signal transduction and posttranslational modifications, and clinical proteomics applications for disease diagnosis and treatment. The Mann lab has pioneered groundbreaking methods like SILAC for quantitative proteomics and MaxQuant for proteome data analysis. Their vision is to translate proteomics knowledge into clinical practice for predictive, diagnostic, and preventive medicine, with recent work focusing on AI-guided platforms for analyzing proteomes from minimal tissue samples. Analysis of Professor Mann's recent publications reveals a strong trend toward clinical applications of proteomics, particularly in cancer research, metabolic diseases, and neurodegenerative disorders. His work increasingly integrates spatial proteomics, single-cell resolution techniques, and artificial intelligence approaches to uncover disease mechanisms and identify potential biomarkers, with a clear shift from basic technology development toward direct clinical applications and personalized medicine. Professor Mann has received numerous prestigious awards throughout his career: 2025: Elected member of the American National Academy of Sciences 2024: Dr. H.P. Heineken Award for Biochemistry and Biophysics 2023: Otto Warburg Medal 2019: Nominated member of the Bavarian Academy of Sciences 2013: Elected member of Leopoldina German National Academy of Sciences 2012: Körber European Science Award, Louis-Jeantet Foundation Prize for Medicine, Ernst Schering Prize, and Leibniz Prize Professor Mann leads a highly collaborative research team involved in multiple international networks including the Bill & Melinda Gates Foundation, Michael J. Fox Foundation for Parkinson's Research, CLINSPECT-M, and Munich Heart Alliance. His lab has mentored numerous successful researchers, with several former postdocs receiving prestigious ERC Starting Grants. The Mann group has developed innovative clinical proteomics pipelines for analyzing archived tissue specimens and body fluids, aiming to identify protein markers for early detection of diseases such as diabetes and cancer. The Mann lab operates across two major research centers with state-of-the-art mass spectrometry facilities. Their Clinical Knowledge Graph platform integrates multi-omics data with extensive metadata, creating an ecosystem for machine learning applications in proteomics. Current research focuses on developing highly sensitive methods that can profile thousands of proteins from minimal cell samples, enabling the identification of critical disease-related proteins and supporting the development of individualized therapies.
Fiona Lee is the Arthur F. Thurnau Professor of Psychology at the University of Michigan, with affiliations in Organizational Studies and the Advisory Committee. She holds a Ph.D. from Harvard University. Her research focuses on three core areas: Identity Integration (how individuals navigate multiple identities), Power Dynamics (effects of power on behavior), and Cultural Differences (impact of cultural contexts on organizations and individuals). She teaches courses on Organizational Psychology and Research Methods in Personality/Social Contexts. Lee’s work bridges social psychology and organizational behavior, emphasizing multicultural experiences and adaptation. Her recent studies explore refugee well-being, racial discrimination coping strategies, and the role of family in resettlement processes. Notably, she investigates how cultural identity integration influences creativity, decision-making, and social tolerance. Her publications span cross-cultural communication, biculturalism, and institutional barriers faced by minorities. Lee’s research often combines qualitative and quantitative methods to address real-world challenges in workplace dynamics and global mobility.
Olivier David Zerbib is an Assistant Professor of Sustainable Finance at CREST, ENSAE, Institut Polytechnique de Paris, and serves as an Associate Editor for the Review of Finance. His research bridges financial theory with environmental sustainability, focusing on market mechanisms for ecological challenges. His primary research areas include sustainable finance, environmental finance, and asset pricing, with specific expertise in green bonds, biodiversity valuation, and climate impact investing. He investigates how pro-environmental preferences influence pricing mechanisms, develops sustainable asset pricing models, and examines shareholder engagement strategies to curb greenwashing through quantitative methodologies. Analysis of his publications reveals a cohesive trajectory toward integrating environmental metrics into core financial frameworks, with significant contributions spanning green bond markets, sustainable CAPM development, and biodiversity economics. His work demonstrates methodological rigor through score-driven conditional betas and empirical validation across global markets. Dr. Zerbib's scientific recognition includes: #1 most cited article in the Journal of Banking and Finance over 3 and 5 years (2019) SUERF/UniCredit Research Prize (2018) Multiple Best Paper Awards at international finance conferences (2017-2020) European Investment Forum Research Prize Finalist (2021) He co-organizes the CMAP-CREST Quantitative Sustainable Economics and Finance seminar series with Patricia Crifo, Emmanuel Gobet, Peter Tankov, and Gauthier Vermandel, fostering collaboration between Ecole Polytechnique and ENSAE on quantitative approaches to sustainability challenges. His presentation record spans elite institutions including LSE, Yale, and the European Commission Joint Research Center.
Jennifer L. Clarke is a Professor in the Department of Statistics at the University of Nebraska–Lincoln and Director of the Quantitative Life Science Initiative. She holds leadership roles in enabling big data integration across the University of Nebraska system through collaborative research programs. Her affiliations include the Institute of Agriculture and Natural Resources (IANR) and the College of Agriculture and Natural Resources. Dr. Clarke's research focuses on statistical methodology for high-dimensional data, computational biology, bioinformatics, and bacterial genomics. Her work bridges statistical innovation with applications in oncology, microbiome analysis, and agricultural phenomics. Key areas include predictive modeling, machine learning, and genomic/metagenomic data integration. Her recent publications span cancer biomarker discovery, plant phenotyping methodologies, and microbial community analysis, reflecting her interdisciplinary approach. Articles emphasize translational applications like therapeutic target identification and precision agriculture. Dr. Clarke leads initiatives fostering collaboration between statisticians and domain scientists, including the Quantitative Life Science Initiative and contributions to the Agricultural Genome-to-Phenome Initiative (AG2PI). Her work advances data-driven solutions for healthcare and food security challenges. Notable projects include developing statistical tools for microbiome studies, analyzing root architecture via 3D imaging, and investigating cranberry-derived compounds' cancer-inhibitory mechanisms. Her methodological contributions include hybrid clustering techniques and predictive model validation frameworks.
Omer Bayraktar is a Group Leader at the Wellcome Sanger Institute , leading research in the Cellular Genomics Programme. His work focuses on decoding human brain cellular diversity using spatial transcriptomics , imaging , and functional screening to study neural complexity in health and disease. Bayraktar's educational background includes a PhD from HHMI under Chris Doe, investigating neural diversity development in Drosophila , followed by postdoctoral work at University of California, San Francisco and University of Cambridge as a Life Sciences Research Foundation Fellow. He developed a spatial transcriptomic pipeline during his postdoc to analyze astrocyte heterogeneity in the cerebral cortex. His research explores neural cell type mapping , glial-neuronal interactions , and cellular pathways in neurodevelopmental disorders . Recent publications emphasize 3D tissue mapping , multi-omic integration , and computational tools like Cell2fate and WebAtlas. His work bridges neurogenetics and computational biology to advance understanding of human tissue ecosystems. Bayraktar's lab collaborates with the Human Cell Atlas initiative and develops technologies such as automated histology pipelines and highly-multiplexed smFISH for molecular cell typing. His team also investigates glia-based therapies and astrocyte functional heterogeneity in neurodevelopmental contexts. Key scientific contributions include: Discovering astrocyte layer patterns independent of neuronal laminae Developing cell2location for spatial cell mapping Characterizing Drosophila neural stem cell models with human relevance Notable awards include the Life Sciences Research Foundation Fellowship during his postdoctoral training. His current group includes a PhD student , Senior Data Scientists , and Bioinformaticians .
Daan Christiaens is a tenure track lecturer at KU Leuven's Faculty of Medicine and Faculty of Engineering Sciences. He is affiliated with the Department of Electrical Engineering (ESAT) and Department of Imaging & Pathology, serving as a member of the Medical Imaging Division and the KU Leuven Brain Institute (LBI). His academic responsibilities include membership in the Faculty Councils of Engineering Sciences and Medicine. His research focuses on: Inverse problems in medical imaging reconstruction Neuroimaging techniques for brain analysis Advanced quantitative MRI methodologies Diffusion-weighted imaging for microstructural assessment Dr. Christiaens' recent publications (2023-2025) demonstrate a consistent focus on diffusion MRI innovations, including novel reconstruction algorithms, neonatal brain development mapping, and clinical applications for neurodegenerative disorders. Key technical themes include motion correction, multi-shell modeling, and AI-enhanced image processing, while clinical applications span Alzheimer's disease, cerebral palsy, and autism research. He leads significant research projects including: MRI reconstruction with dynamic field monitoring (2024-2028) Compressed sensing for microstructure imaging (2022-2026) Neonatal diffusion MRI network connectivity analysis (2024-2028) As a core developer of the MRtrix3 software framework for medical image processing, he contributes to essential tools in neuroimaging research.
Brendan T. O'Connor is an Associate Professor at the College of Information and Computer Sciences, University of Massachusetts Amherst, where he directs the SLANG Lab and serves as Associate Director of the Computational Social Science Institute. His research bridges statistical machine learning and natural language processing with social science applications, particularly using text data from news and social media to understand societal patterns. His work focuses on developing text analysis methods to answer social science questions in domains like political science and sociolinguistics. Current collaborative projects include combating misinformation, analyzing bias in news coverage, and developing tools for clinical discourse assessment using large language models. O'Connor's publications demonstrate a consistent focus on computational social science, with recent work exploring multilingual analysis, legal discourse patterns, and sociolinguistic variation. His methodological contributions span coreference resolution, event extraction, and argument mining. At UMass, he contributes to multiple research centers including the Computational Social Science Institute, UMass NLP group, and Centers for Data Science and Intelligent Information Retrieval. He teaches graduate seminars in natural language processing and maintains active collaborations across disciplines.
Professor Hak-Kim Chan of the Sydney Pharmacy School at the University of Sydney is a world-renowned expert in respiratory drug delivery, particularly pulmonary aerosols and inhalation therapies. With over 480 publications and 17,580+ Google Scholar citations, he has pioneered advancements in powder formulation , in silico modeling , and clinical applications of inhalation technologies. His work includes the development of FDA-approved diagnostics like Aridol™ (inhaled mannitol for asthma) and Bronchitol™ (for cystic fibrosis), and groundbreaking research on inhaled bacteriophage therapy to combat antibiotic-resistant respiratory infections. Education: BPharm (University Medal, 1983), PhD (1988), DSc (2009) from University of Sydney Professional Experience: Postdoc at University of Minnesota (1988–89), Scientist at Genentech Inc. (1992–95) Leadership: Executive Editor of Advanced Drug Delivery Reviews , Fellow of AAPS and RACI His research spans in vitro production methods, computational modeling of inhaler design, and in vivo imaging of aerosol deposition. Current projects focus on nanomedicine , phage therapy , and combating superbugs via inhalation routes. He has secured significant recognition for his work, including NHMRC case studies highlighting public health impacts. Professor Chan has supervised numerous researchers, including PhD student Grace YAU studying pulmonary probiotic delivery . His team's 10 patents (7 as first inventor) reflect practical innovations in dry powder inhalers , antimicrobial formulations , and drug stabilization technologies.
Nasir M. Rajpoot is a Professor in the Department of Computer Science at the University of Warwick, UK. His research focuses on computational pathology, medical image analysis, and deep learning applications in histology. He leads interdisciplinary projects integrating artificial intelligence with healthcare, particularly in cancer diagnostics and pathology workflows. Rajpoot’s work emphasizes developing robust algorithms for histology image analysis, including nuclear segmentation, tumor classification, and domain generalization in computational pathology. His contributions include the TIAToolbox, an open-source framework for tissue image analytics, and the CoNIC Challenge to advance nuclear detection and counting in histology images. He collaborates with clinicians and biologists to translate AI models into clinical practice, addressing challenges like tumor heterogeneity and staining variability. Rajpoot’s research spans colorectal, lung, and oral cancers, with a focus on predicting clinical outcomes via histological features and genomic data integration. Notable projects include the development of Handcrafted Histological Transformer (H2T) for unsupervised representations of whole slide images and the SAFRON framework for histology image synthesis. His work addresses domain adaptation, robustness evaluation, and explainability in AI-driven pathology systems.
